Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure

BACKGROUND: Ferroquine (FQ), or SSR97193, is a novel antimalarial drug currently in phase I clinical trials. FQ is a unique organometallic compound designed to overcome the chloroquine (CQ) resistance problem. FQ revealed to be equally active on CQ-sensitive and CQ-resistant Plasmodium falciparum la...

Descripción completa

Detalles Bibliográficos
Autores principales: Daher, Wassim, Biot, Christophe, Fandeur, Thierry, Jouin, Helene, Pelinski, Lydie, Viscogliosi, Eric, Fraisse, Laurent, Pradines, Bruno, Brocard, Jacques, Khalife, Jamal, Dive, Daniel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1395321/
https://www.ncbi.nlm.nih.gov/pubmed/16464254
http://dx.doi.org/10.1186/1475-2875-5-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1395321/
https://www.ncbi.nlm.nih.gov/pubmed/16464254
http://dx.doi.org/10.1186/1475-2875-5-11

Ejemplares similares